GlassScriptPhysician profile
Stephen J Pickett
NPI 1417336199
$29,374.87
in general payments reported to CMS, 2019-2025
40 companies · $2,363 in 2025
The $2,363 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,792 · 2020: $4,136 · 2021: $1,096 · 2022: $6,664 · 2023: $6,046 · 2024: $3,278 · 2025: $2,363.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $11K · Travel and Lodging: $1,134.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $10,553.33 |
| Travel and Lodging | $1,133.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $16,047.62 | 2019-2025 | Supera, Gallant, Aveir |
| Boston Scientific Corporation | $2,115.21 | 2019-2025 | Ilab Ultrasound Imaging System, Emerge Push, Lux-Dx Insertable Cardiac Monitor |
| Edwards Lifesciences Corporation | $1,713.64 | 2021-2025 | |
| Abiomed | $1,643.40 | 2021-2025 | Impella |
| Medtronic, INC. | $1,310.31 | 2022-2025 | Micra, Onyx Frontier, Symplicity G3 |
| Amgen INC. | $870.22 | 2019-2025 | Repatha, Repatha |
| Novartis Pharmaceuticals Corporation | $751.42 | 2021-2025 | |
| Cvrx, INC. | $573.92 | 2022-2024 | Barostim Neo System |
| Inari Medical, INC. | $449.10 | 2021-2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Cardiovascular Systems INC. | $417.01 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $411.78 | 2022-2025 | Verquvo, Capvaxive |
| Shockwave Medical, INC | $402.70 | 2024-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Janssen Pharmaceuticals, INC | $353.86 | 2019-2024 | Xarelto |
| Biotronik INC. | $303.13 | 2019-2022 | |
| Impulse Dynamics (USA) INC. | $273.10 | 2022-2024 | Optimizer |
Show all 40 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephen Pickett listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.